FDA approves cabotegravir LA; New HIV PrEP option fills an important gapDecember 21, 2021HIVInfectious Diseases
FDA agrees that mifepristone is safe enough to dispense by mailDecember 20, 2021Women's HealthBusiness of Medicine
FDA grants new indication to lumateperone (Caplyta) for bipolar depressionDecember 20, 2021DepressionMental Health
More evidence ties some antipsychotics to increased breast cancer riskDecember 15, 2021Breast CancerOncologyMental HealthCancer
Isatuximab added to RVd boosts response in new myelomaDecember 13, 2021Multiple MyelomaHematologic Malignancies
Antibiotic use associated with triple-negative breast cancer mortalityDecember 13, 2021OncologyBreast CancerCancer
Women struggle with benzodiazepine addiction post chemotherapy treatmentDecember 13, 2021OncologyBreast CancerAddiction MedicineCancer
Assessing Outcomes Between Risperidone Microspheres and Paliperidone Palmitate Long-Acting Injectable Antipsychotics Among VeteransDecember 10, 2021Mental HealthHospital Medicine
New data on rare myocarditis after COVID-19 vaccinationDecember 8, 2021COVID-19 UpdatesCardiologyInfectious Diseases
FDA expands pembrolizumab approval for advanced melanomaDecember 8, 2021MelanomaDermatologyOncologyCancer
